Leadership

Message from President Director

Ever since its establishment in 1985, PT Anugerah Pharmindo Lestari (APL), with uncompromising our integrity in delivering the high-standard of pharma-distribution has strived to innovate in achieving our ultimate purpose of making healthcare more accessible in Indonesia. Our expertise covers three primary areas; distribution; commercialization or ZP Therapeutics; and digital & data analytic tools.

APL has been focusing on leveraging its strengths to promote digital transformation and sustainability to change our lives and ability to help patients more. Our sustainability program is arranged under 4 pillars of improving health outcomes, nurturing talent, respecting environment, and setting the highest standard of integrity.

Our ambition has been driven by the collaboration of the team who are working with the high spirit and committed to reach our full potential to focus in patients live and well-being.

We look forward to your continued support and patronage. We shall identify new opportunities to pursue the fulfilment of our main mission, using the impact of our support as a main driver in making healthcare more accessible in Indonesia.

Christophe Piganiol President Director of PT Anugerah Pharmindo Lestari

Show More Show Less

Our Leadership

High-qualified leaders with diverse and complementary expertise who are passionate in realizing our very fundamental purpose, making healthcare more accessible for all the patients in Indonesia together with our Clients and Customers

Christophe Piganiol
President Director
Denny Fikri
Chief Operating Officer Distribution
Jesianto Nugroho
Chief Financial Officer
Aylie Widjaja
Chief Operating Officer
ZP Therapeutics
Achmad Nurfian
Vice President
Human Capital (OIC)
Dannarjaya Harinta Sri
Vice President
Operation & Technology
Janiwati Widjaja
Head of Customer Development
Haryadi Wangsadjaja
General Manager
Consumer Healthcare
Ratna Kurniawati
General Manager
Medical Devices & Diagnostics
Berthalina Kartadjaja
General Manager
Sales Pharma